Skip to main content
. 2021 Apr 7;2(6):937–947. doi: 10.34067/KID.0000302021

Table 3.

Treatment parameters applied in study phases using indicated dialyzer

Treatment parameter FX CorAL 600 (N=58) SureFlux 17UX (N=58) Polyflux 170H (N=58)
Parameter, mean±SD
 Effective blood flow rate (ml/min) 306±29 303±25 305±26
 Dialysate flow rate (ml/min) 500±0.1 500±0.3 500±0.0
 Substitution volume (L) 17.6±4.5 15.3±2.8 17.4±4.8
 Ultrafiltration volume (L) 2.2±1.2 2.2±1.3 2.2±1.3
 Effective treatment time (min) 272±29 270±29 270±29
Anticoagulation (% of patients)
 Unfractionated heparin (bolus and infusion) 79 81 79
 Low mol wt heparin (bolus and infusion) 9 7 9
 Low mol wt heparin (bolus) 12 12 12